Glenn E. Pauly

Mr. Pauly brings more than 20 years of commercial launch experience in the biopharma industry to the Alzheon team. He has extensive experience with disease-modifying agents in multiple therapeutic areas and across multiple commercial functions including sales, account management and market access. Most recently, Mr. Pauly was a Division General Manager and Vice President for Alzheimer’s Disease at Biogen with responsibility for commercialization of Aduhelm® in the West Division of the U.S.

Previously, Mr. Pauly has held commercial and executive roles at Johnson & Johnson, Genentech, and AstraZeneca, where he supported successful launches and commercialization for multiple products including Remicade®, Actemra®, Xolair® and Fasenra®.

Mr. Pauly received his Bachelor of Arts in Communications from Loras College located in Dubuque, Iowa.